A recent study suggests that patients who discontinue popular slimming jabs like Mounjaro or Wegovy can put back on shed pounds at a significantly accelerated pace than those who stop conventional diet and exercise programs.
Published data in a major medical journal demonstrates that while overweight people frequently drop a large proportion of their body weight while undergoing treatment, the mass comes back at an estimated rate of 0.8 kg per month once they quit.
"Individuals buying these drugs should be informed of the danger of quick rebound weight gain when the therapy concludes," warns researcher Dr. Susan Jebb.
This pace of regain implies a return to original weight in about a year and a half.
Analyzing Treatments
The research, which examined 37 of trials involving over 9,000 of participants, compared the effects of the injectable medications with conventional dieting.
The team point out that individuals who shed pounds through lifestyle changes alone generally see a more gradual creep back—around 100 grams monthly—after stopping.
Understanding the Fast Regain
Experts suggest the mechanism of the drugs accounts for the accelerated regain.
The injections imitate a body's own chemical called GLP-1, which controls hunger.
"Artificially providing the hormone concentrations several times higher than the body's typical production may cause the body to produce less of its endogenous GLP-1, and may also diminish sensitivity to its actions," noted Dr. Adam Collins, a nutrition expert.
"Discontinuation of this hormone supplement leads to appetite is no longer kept in check, making excessive eating a significant risk."
A Lifelong Disease?
Medical guidelines advise the jabs for individuals with weight-linked medical conditions, alongside recommended lifestyle changes.
A number of clinicians contend that, considering the significant potential of relapse, the therapy might need to be life-long.
This perspective is reinforced by pharmaceutical companies, who say that the findings "emphasize the persistent nature of excess weight," comparing it to managing diseases like diabetes.
User Accounts
Users who have discontinued the medication describe a sudden resurgence of cravings.
"It felt as if a switch activating and you're instantly extremely hungry," recalled an individual.
This challenge is exacerbated if users have not established sustainable lifestyle or habit changes during therapy.
Widespread Use
Figures suggest that a significant number of people in the UK have tried these injections in the last 12 months, with desire being substantial.
- Use is higher among women compared to men.
- The 40s and 50s age group shows the greatest usage rates.
- Many obtain the medications through private prescriptions rather than the NHS.
In conclusion, researchers caution that while GLP-1 drugs are powerful tools for shedding pounds, they are not a permanent solution and long-term success relies on combined lifestyle support.
